View Financial HealthBalaji Amines 배당 및 자사주 매입배당 기준 점검 4/6Balaji Amines 수익으로 충분히 충당되는 현재 수익률 0.6% 보유한 배당금 지급 회사입니다.핵심 정보0.6%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향23%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).공시 • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.분석 기사 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.공시 • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.공시 • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.모든 업데이트 보기Recent updates분석 기사 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹1,833, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change).Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,492, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 36% over the past three years.공시 • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change).공시 • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,265, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.분석 기사 • Jan 09Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...Price Target Changed • Nov 15Price target decreased by 7.5% to ₹1,709Down from ₹1,847, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₹1,229. Stock is down 40% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.분석 기사 • Nov 14Balaji Amines Limited (NSE:BALAMINES) Screens Well But There Might Be A CatchWith a median price-to-earnings (or "P/E") ratio of close to 27x in India, you could be forgiven for feeling...Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹10.67 (vs ₹12.65 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.67 (down from ₹12.65 in 2Q 2025). Revenue: ₹3.48b (flat on 2Q 2025). Net income: ₹345.6m (down 16% from 2Q 2025). Profit margin: 9.9% (down from 12% in 2Q 2025). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.공시 • Nov 03Balaji Amines Limited to Report Q2, 2026 Results on Nov 10, 2025Balaji Amines Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 10, 2025Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).공시 • Jul 24Balaji Amines Limited to Report Q1, 2026 Results on Aug 02, 2025Balaji Amines Limited announced that they will report Q1, 2026 results at 3:30 PM, Indian Standard Time on Aug 02, 2025Reported Earnings • Jul 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.0b (down 15% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공시 • Jul 10Balaji Amines Limited, Annual General Meeting, Aug 08, 2025Balaji Amines Limited, Annual General Meeting, Aug 08, 2025, at 12:00 Indian Standard Time.Price Target Changed • Jul 01Price target increased by 20% to ₹1,972Up from ₹1,640, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of ₹1,825. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.분석 기사 • Jul 01Earnings Tell The Story For Balaji Amines Limited (NSE:BALAMINES) As Its Stock Soars 27%Balaji Amines Limited ( NSE:BALAMINES ) shares have continued their recent momentum with a 27% gain in the last month...Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,673, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 31x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.Reported Earnings • May 29Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.3b (down 13% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.공시 • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.공시 • May 18Balaji Amines Limited to Report Q4, 2025 Results on May 26, 2025Balaji Amines Limited announced that they will report Q4, 2025 results on May 26, 2025분석 기사 • May 17Balaji Amines (NSE:BALAMINES) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...Buy Or Sell Opportunity • May 16Now 21% overvaluedOver the last 90 days, the stock has fallen 2.1% to ₹1,404. The fair value is estimated to be ₹1,163, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,312, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.분석 기사 • Mar 25A Look At The Fair Value Of Balaji Amines Limited (NSE:BALAMINES)Key Insights The projected fair value for Balaji Amines is ₹1,139 based on 2 Stage Free Cash Flow to Equity Current...Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,358, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.분석 기사 • Mar 04Take Care Before Jumping Onto Balaji Amines Limited (NSE:BALAMINES) Even Though It's 25% CheaperUnfortunately for some shareholders, the Balaji Amines Limited ( NSE:BALAMINES ) share price has dived 25% in the last...Buy Or Sell Opportunity • Feb 19Now 23% overvaluedOver the last 90 days, the stock has fallen 30% to ₹1,395. The fair value is estimated to be ₹1,130, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.분석 기사 • Feb 18This Analyst Just Downgraded Their Balaji Amines Limited (NSE:BALAMINES) EPS ForecastsMarket forces rained on the parade of Balaji Amines Limited ( NSE:BALAMINES ) shareholders today, when the covering...분석 기사 • Feb 16Earnings Report: Balaji Amines Limited Missed Revenue Estimates By 15%It's been a sad week for Balaji Amines Limited ( NSE:BALAMINES ), who've watched their investment drop 17% to ₹1,433 in...Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹10.24 (vs ₹15.24 in 3Q 2024)Third quarter 2025 results: EPS: ₹10.24 (down from ₹15.24 in 3Q 2024). Revenue: ₹3.21b (down 16% from 3Q 2024). Net income: ₹331.9m (down 33% from 3Q 2024). Profit margin: 10% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.공시 • Feb 05Balaji Amines Limited to Report Q3, 2025 Results on Feb 12, 2025Balaji Amines Limited announced that they will report Q3, 2025 results on Feb 12, 2025Buy Or Sell Opportunity • Jan 30Now 21% overvaluedOver the last 90 days, the stock has fallen 22% to ₹1,683. The fair value is estimated to be ₹1,385, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Earnings per share has declined by 25%. Revenue is forecast to grow by 42% in 2 years. Earnings are forecast to grow by 96% in the next 2 years.분석 기사 • Jan 17What Does Balaji Amines Limited's (NSE:BALAMINES) Share Price Indicate?Balaji Amines Limited ( NSE:BALAMINES ), might not be a large cap stock, but it saw significant share price movement...분석 기사 • Dec 31Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Price Target Changed • Nov 20Price target decreased by 12% to ₹2,328Down from ₹2,648, the current price target is provided by 1 analyst. New target price is 17% above last closing price of ₹1,996. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₹54.20 for next year compared to ₹63.22 last year.Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹12.65 (vs ₹10.71 in 2Q 2024)Second quarter 2025 results: EPS: ₹12.65 (up from ₹10.71 in 2Q 2024). Revenue: ₹3.56b (down 6.4% from 2Q 2024). Net income: ₹409.8m (up 18% from 2Q 2024). Profit margin: 12% (up from 9.1% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.공시 • Nov 14Balaji Amines Limited Announces Company Secretary ChangesBalaji Amines Limited announced that at the board meeting held on November 14, 2024, approved the resignation of Mr. Lakhan S. Dargad as Company Secretary of the Company with effect from closing of business hours on December 30, 2024. Appointment of Mr. Abhijeet S. Kothadiya as a Company Secretary of the Company with effect from December 31, 2024. Mr. Abhijeet S. Kothadiya is an Associate Member of the Institute of Company Secretaries of India having Membership No. 68288 having good amount of experience in corporate and allied laws.공시 • Nov 06Balaji Amines Limited to Report Q2, 2025 Results on Nov 14, 2024Balaji Amines Limited announced that they will report Q2, 2025 results on Nov 14, 2024분석 기사 • Oct 23Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...분석 기사 • Aug 13The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%The analyst covering Balaji Amines Limited ( NSE:BALAMINES ) delivered a dose of negativity to shareholders today, by...분석 기사 • Aug 11Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than ExpectedShareholders might have noticed that Balaji Amines Limited ( NSE:BALAMINES ) filed its quarterly result this time last...Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹13.36 (vs ₹16.28 in 1Q 2024)First quarter 2025 results: EPS: ₹13.36 (down from ₹16.28 in 1Q 2024). Revenue: ₹3.93b (down 15% from 1Q 2024). Net income: ₹432.9m (down 18% from 1Q 2024). Profit margin: 11% (in line with 1Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.분석 기사 • Jul 30At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?Balaji Amines Limited ( NSE:BALAMINES ), is not the largest company out there, but it saw a double-digit share price...공시 • Jul 26Balaji Amines Limited to Report Q1, 2025 Results on Aug 07, 2024Balaji Amines Limited announced that they will report Q1, 2025 results on Aug 07, 2024Reported Earnings • Jun 23Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.4b (down 30% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 13% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.분석 기사 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...공시 • Jun 19Balaji Amines Limited, Annual General Meeting, Jul 11, 2024Balaji Amines Limited, Annual General Meeting, Jul 11, 2024, at 12:00 Indian Standard Time.Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.분석 기사 • Jun 12Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • May 09Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.7b (down 29% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.공시 • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.공시 • May 03Balaji Amines Limited to Report Q4, 2024 Results on May 08, 2024Balaji Amines Limited announced that they will report Q4, 2024 results on May 08, 2024분석 기사 • Apr 05There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...분석 기사 • Feb 15Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) ForecastsToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the covering analyst...Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹15.24 (vs ₹19.31 in 3Q 2023)Third quarter 2024 results: EPS: ₹15.24 (down from ₹19.31 in 3Q 2023). Revenue: ₹3.92b (down 33% from 3Q 2023). Net income: ₹493.7m (down 21% from 3Q 2023). Profit margin: 13% (up from 11% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.공시 • Jan 24Balaji Amines Limited to Report Q3, 2024 Results on Jan 31, 2024Balaji Amines Limited announced that they will report Q3, 2024 results on Jan 31, 2024Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,670, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,718 per share.Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,347, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 159% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,738 per share.분석 기사 • Nov 24Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To BeToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the analysts delivering a...Price Target Changed • Nov 22Price target decreased by 16% to ₹2,768Down from ₹3,278, the current price target is an average from 2 analysts. New target price is 36% above last closing price of ₹2,030. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹125 for next year compared to ₹100 last year.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹10.71 (vs ₹28.57 in 2Q 2023)Second quarter 2024 results: EPS: ₹10.71 (down from ₹28.57 in 2Q 2023). Revenue: ₹3.87b (down 39% from 2Q 2023). Net income: ₹347.1m (down 63% from 2Q 2023). Profit margin: 9.0% (down from 15% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.공시 • Nov 03Balaji Amines Limited to Report Q2, 2024 Results on Nov 08, 2023Balaji Amines Limited announced that they will report Q2, 2024 results on Nov 08, 2023Reported Earnings • Sep 01First quarter 2024 earnings released: EPS: ₹16.28 (vs ₹37.95 in 1Q 2023)First quarter 2024 results: EPS: ₹16.28 (down from ₹37.95 in 1Q 2023). Revenue: ₹4.69b (down 31% from 1Q 2023). Net income: ₹527.3m (down 57% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.공시 • Aug 22Balaji Amines Limited to Report Q1, 2024 Results on Aug 31, 2023Balaji Amines Limited announced that they will report Q1, 2024 results on Aug 31, 2023분석 기사 • Jul 14Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?Key Insights Using the 2 Stage Free Cash Flow to Equity, Balaji Amines fair value estimate is ₹3,541 Current share...공시 • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.Upcoming Dividend • Jun 26Upcoming dividend of ₹10.00 per share at 0.4% yieldEligible shareholders must have bought the stock before 03 July 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).Reported Earnings • Jun 24Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.6b (up 1.4% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Jun 22Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...공시 • Jun 17Balaji Amines Limited, Annual General Meeting, Jul 10, 2023Balaji Amines Limited, Annual General Meeting, Jul 10, 2023, at 16:00 Indian Standard Time.분석 기사 • Jun 09Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last YearBalaji Amines Limited ( NSE:BALAMINES ) has announced that it will be increasing its dividend from last year's...Reported Earnings • May 25Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.7b (up 2.0% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 74% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 22+ 1 more updateBalaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial OfficerBalaji Amines Limited announced resignation of Hemanth Reddy Gaddam as Chief Financial Officer. The full-time director and CFO has resigned to focus on subsidiary company, Balaji Speciality Chemicals Ltd.공시 • May 21+ 1 more updateBalaji Amines Limited Appoints Ande Srinivas Reddy as CFOBalaji Amines Limited at the SBM, the board approved appointment of Mr. Ande Srinivas Reddy (DIN: 03169721) as a Whole-time Director & CFO of the Company for remaining tenure of his appointment till 31st March, 2026.공시 • May 14Balaji Amines Limited to Report Q4, 2023 Results on May 20, 2023Balaji Amines Limited announced that they will report Q4, 2023 results on May 20, 2023Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,486, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 685% over the past three years.Price Target Changed • Apr 05Price target decreased by 14% to ₹3,790Down from ₹4,428, the current price target is provided by 1 analyst. New target price is 78% above last closing price of ₹2,128. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹142 for next year compared to ₹114 last year.분석 기사 • Apr 05Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?While Balaji Amines Limited ( NSE:BALAMINES ) might not be the most widely known stock at the moment, it saw...Recent Insider Transactions • Mar 22MD & Whole Time Director recently bought ₹202k worth of stockOn the 16th of March, Dundurapu Reddy bought around 100 shares on-market at roughly ₹2,019 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. Dundurapu has been a buyer over the last 12 months, purchasing a net total of ₹419k worth in shares.분석 기사 • Mar 15Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Recent Insider Transactions • Feb 22Joint MD & Whole-time Director recently bought ₹244k worth of stockOn the 16th of February, Nomula Reddy bought around 98.0 shares on-market at roughly ₹2,494 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. This was Nomula's only on-market trade for the last 12 months.분석 기사 • Feb 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under ThreatOne thing we could say about the analysts on Balaji Amines Limited ( NSE:BALAMINES ) - they aren't optimistic, having...Recent Insider Transactions • Feb 14Executive Chairman recently bought ₹1.0m worth of stockOn the 10th of February, Ande Reddy bought around 480 shares on-market at roughly ₹2,166 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ande's only on-market trade for the last 12 months.분석 기사 • Feb 08With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting CaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Feb 07Third quarter 2023 earnings released: EPS: ₹19.31 (vs ₹27.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹19.31 (down from ₹27.64 in 3Q 2022). Revenue: ₹5.88b (up 4.2% from 3Q 2022). Net income: ₹625.7m (down 30% from 3Q 2022). Profit margin: 11% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has increased by 72% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jan 31Balaji Amines Limited to Report Q3, 2023 Results on Feb 06, 2023Balaji Amines Limited announced that they will report Q3, 2023 results on Feb 06, 2023분석 기사 • Dec 25Balaji Amines (NSE:BALAMINES) Seems To Use Debt Quite SensiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...분석 기사 • Dec 02Why The 42% Return On Capital At Balaji Amines (NSE:BALAMINES) Should Have Your AttentionFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Price Target Changed • Nov 16Price target increased to ₹4,428Up from ₹4,115, the current price target is an average from 2 analysts. New target price is 50% above last closing price of ₹2,958. Stock is down 9.6% over the past year. The company is forecast to post earnings per share of ₹143 for next year compared to ₹114 last year.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 10 highly experienced directors. Independent Non-Executive Director Vimala Madon was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: BALAMINES 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: BALAMINES 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Balaji Amines 배당 수익률 vs 시장BALAMINES의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (BALAMINES)0.6%시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Chemicals)0.8%분석가 예측 (BALAMINES) (최대 3년)n/a주목할만한 배당금: BALAMINES 의 배당금( 0.6% )은 Indian 시장에서 배당금 지급자의 하위 25%( 0.3% )보다 높습니다.고배당: BALAMINES 의 배당금( 0.6% )은 Indian 시장에서 배당금 지급자의 상위 25%( 1.47% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 지급 비율 ( 22.6% )이 낮기 때문에 BALAMINES 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: BALAMINES 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 11:46종가2026/05/22 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Balaji Amines Limited는 4명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Nilesh GhugeHDFC Securities LimitedJay GandhiHDFC Securities LimitedKeshav LahotiHDFC Securities Limited1명의 분석가 더 보기
Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).
공시 • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.
분석 기사 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...
Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.
공시 • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.
분석 기사 • May 21Balaji Amines' (NSE:BALAMINES) Solid Earnings May Rest On Weak FoundationsBalaji Amines Limited ( NSE:BALAMINES ) just released a solid earnings report, and the stock displayed some strength...
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹1,833, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 14% over the past three years.
Reported Earnings • May 15Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹51.60 (up from ₹48.62 in FY 2025). Revenue: ₹14.5b (up 4.1% from FY 2025). Net income: ₹1.67b (up 6.1% from FY 2025). Profit margin: 12% (in line with FY 2025). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 4.3%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change).
Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,492, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 36% over the past three years.
공시 • May 04Balaji Amines Limited to Report Q4, 2026 Results on May 13, 2026Balaji Amines Limited announced that they will report Q4, 2026 results on May 13, 2026
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹9.49 (vs ₹10.24 in 3Q 2025)Third quarter 2026 results: EPS: ₹9.49 (down from ₹10.24 in 3Q 2025). Revenue: ₹3.31b (up 5.9% from 3Q 2025). Net income: ₹314.3m (down 5.3% from 3Q 2025). Profit margin: 9.5% (down from 11% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.
New Risk • Jan 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change).
공시 • Jan 19Balaji Amines Limited to Report Q3, 2026 Results on Jan 29, 2026Balaji Amines Limited announced that they will report Q3, 2026 results on Jan 29, 2026
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹1,265, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.
분석 기사 • Jan 09Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Nov 17Balaji Amines' (NSE:BALAMINES) Shareholders Have More To Worry About Than Only Soft EarningsLast week's earnings announcement from Balaji Amines Limited ( NSE:BALAMINES ) was disappointing to investors, with a...
Price Target Changed • Nov 15Price target decreased by 7.5% to ₹1,709Down from ₹1,847, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ₹1,229. Stock is down 40% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.
분석 기사 • Nov 14Balaji Amines Limited (NSE:BALAMINES) Screens Well But There Might Be A CatchWith a median price-to-earnings (or "P/E") ratio of close to 27x in India, you could be forgiven for feeling...
Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹10.67 (vs ₹12.65 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.67 (down from ₹12.65 in 2Q 2025). Revenue: ₹3.48b (flat on 2Q 2025). Net income: ₹345.6m (down 16% from 2Q 2025). Profit margin: 9.9% (down from 12% in 2Q 2025). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
공시 • Nov 03Balaji Amines Limited to Report Q2, 2026 Results on Nov 10, 2025Balaji Amines Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 10, 2025
Upcoming Dividend • Jul 25Upcoming dividend of ₹11.00 per shareEligible shareholders must have bought the stock before 01 August 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.2%). In line with average of industry peers (0.7%).
공시 • Jul 24Balaji Amines Limited to Report Q1, 2026 Results on Aug 02, 2025Balaji Amines Limited announced that they will report Q1, 2026 results at 3:30 PM, Indian Standard Time on Aug 02, 2025
Reported Earnings • Jul 16Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.0b (down 15% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공시 • Jul 10Balaji Amines Limited, Annual General Meeting, Aug 08, 2025Balaji Amines Limited, Annual General Meeting, Aug 08, 2025, at 12:00 Indian Standard Time.
Price Target Changed • Jul 01Price target increased by 20% to ₹1,972Up from ₹1,640, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of ₹1,825. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹63.56 for next year compared to ₹48.62 last year.
분석 기사 • Jul 01Earnings Tell The Story For Balaji Amines Limited (NSE:BALAMINES) As Its Stock Soars 27%Balaji Amines Limited ( NSE:BALAMINES ) shares have continued their recent momentum with a 27% gain in the last month...
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,673, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 31x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.
Reported Earnings • May 29Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹48.62 (down from ₹63.22 in FY 2024). Revenue: ₹14.3b (down 13% from FY 2024). Net income: ₹1.58b (down 23% from FY 2024). Profit margin: 11% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
공시 • May 28Balaji Amines Limited Recommends Final DividendBalaji Amines Limited at its board of directors meeting held on May 28, 2025, recommended a final dividend of INR 11.00 per equity share i.e. 550% on face value of INR 2.00 per share and the same will be payable after it is approved by the shareholders at the 37th Annual General Meeting of the Company.
공시 • May 18Balaji Amines Limited to Report Q4, 2025 Results on May 26, 2025Balaji Amines Limited announced that they will report Q4, 2025 results on May 26, 2025
분석 기사 • May 17Balaji Amines (NSE:BALAMINES) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
Buy Or Sell Opportunity • May 16Now 21% overvaluedOver the last 90 days, the stock has fallen 2.1% to ₹1,404. The fair value is estimated to be ₹1,163, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,312, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.
분석 기사 • Mar 25A Look At The Fair Value Of Balaji Amines Limited (NSE:BALAMINES)Key Insights The projected fair value for Balaji Amines is ₹1,139 based on 2 Stage Free Cash Flow to Equity Current...
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,358, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.
분석 기사 • Mar 04Take Care Before Jumping Onto Balaji Amines Limited (NSE:BALAMINES) Even Though It's 25% CheaperUnfortunately for some shareholders, the Balaji Amines Limited ( NSE:BALAMINES ) share price has dived 25% in the last...
Buy Or Sell Opportunity • Feb 19Now 23% overvaluedOver the last 90 days, the stock has fallen 30% to ₹1,395. The fair value is estimated to be ₹1,130, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Earnings per share has declined by 29%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 71% in the next 2 years.
분석 기사 • Feb 18This Analyst Just Downgraded Their Balaji Amines Limited (NSE:BALAMINES) EPS ForecastsMarket forces rained on the parade of Balaji Amines Limited ( NSE:BALAMINES ) shareholders today, when the covering...
분석 기사 • Feb 16Earnings Report: Balaji Amines Limited Missed Revenue Estimates By 15%It's been a sad week for Balaji Amines Limited ( NSE:BALAMINES ), who've watched their investment drop 17% to ₹1,433 in...
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹10.24 (vs ₹15.24 in 3Q 2024)Third quarter 2025 results: EPS: ₹10.24 (down from ₹15.24 in 3Q 2024). Revenue: ₹3.21b (down 16% from 3Q 2024). Net income: ₹331.9m (down 33% from 3Q 2024). Profit margin: 10% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
공시 • Feb 05Balaji Amines Limited to Report Q3, 2025 Results on Feb 12, 2025Balaji Amines Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Buy Or Sell Opportunity • Jan 30Now 21% overvaluedOver the last 90 days, the stock has fallen 22% to ₹1,683. The fair value is estimated to be ₹1,385, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Earnings per share has declined by 25%. Revenue is forecast to grow by 42% in 2 years. Earnings are forecast to grow by 96% in the next 2 years.
분석 기사 • Jan 17What Does Balaji Amines Limited's (NSE:BALAMINES) Share Price Indicate?Balaji Amines Limited ( NSE:BALAMINES ), might not be a large cap stock, but it saw significant share price movement...
분석 기사 • Dec 31Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt ResponsiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Price Target Changed • Nov 20Price target decreased by 12% to ₹2,328Down from ₹2,648, the current price target is provided by 1 analyst. New target price is 17% above last closing price of ₹1,996. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₹54.20 for next year compared to ₹63.22 last year.
Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹12.65 (vs ₹10.71 in 2Q 2024)Second quarter 2025 results: EPS: ₹12.65 (up from ₹10.71 in 2Q 2024). Revenue: ₹3.56b (down 6.4% from 2Q 2024). Net income: ₹409.8m (up 18% from 2Q 2024). Profit margin: 12% (up from 9.1% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
공시 • Nov 14Balaji Amines Limited Announces Company Secretary ChangesBalaji Amines Limited announced that at the board meeting held on November 14, 2024, approved the resignation of Mr. Lakhan S. Dargad as Company Secretary of the Company with effect from closing of business hours on December 30, 2024. Appointment of Mr. Abhijeet S. Kothadiya as a Company Secretary of the Company with effect from December 31, 2024. Mr. Abhijeet S. Kothadiya is an Associate Member of the Institute of Company Secretaries of India having Membership No. 68288 having good amount of experience in corporate and allied laws.
공시 • Nov 06Balaji Amines Limited to Report Q2, 2025 Results on Nov 14, 2024Balaji Amines Limited announced that they will report Q2, 2025 results on Nov 14, 2024
분석 기사 • Oct 23Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
분석 기사 • Aug 13The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%The analyst covering Balaji Amines Limited ( NSE:BALAMINES ) delivered a dose of negativity to shareholders today, by...
분석 기사 • Aug 11Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than ExpectedShareholders might have noticed that Balaji Amines Limited ( NSE:BALAMINES ) filed its quarterly result this time last...
Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹13.36 (vs ₹16.28 in 1Q 2024)First quarter 2025 results: EPS: ₹13.36 (down from ₹16.28 in 1Q 2024). Revenue: ₹3.93b (down 15% from 1Q 2024). Net income: ₹432.9m (down 18% from 1Q 2024). Profit margin: 11% (in line with 1Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
분석 기사 • Jul 30At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?Balaji Amines Limited ( NSE:BALAMINES ), is not the largest company out there, but it saw a double-digit share price...
공시 • Jul 26Balaji Amines Limited to Report Q1, 2025 Results on Aug 07, 2024Balaji Amines Limited announced that they will report Q1, 2025 results on Aug 07, 2024
Reported Earnings • Jun 23Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.4b (down 30% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 13% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
분석 기사 • Jun 20Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00The board of Balaji Amines Limited ( NSE:BALAMINES ) has announced that it will be paying its dividend of ₹11.00 on the...
공시 • Jun 19Balaji Amines Limited, Annual General Meeting, Jul 11, 2024Balaji Amines Limited, Annual General Meeting, Jul 11, 2024, at 12:00 Indian Standard Time.
Declared Dividend • Jun 19Dividend increased to ₹11.00Dividend of ₹11.00 is 10% higher than last year. Ex-date: 4th July 2024 Payment date: 10th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (17% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 30% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 74% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
분석 기사 • Jun 12Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • May 09Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: ₹63.22 (down from ₹100 in FY 2023). Revenue: ₹16.7b (down 29% from FY 2023). Net income: ₹2.05b (down 37% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
공시 • May 09Balaji Amines Limited Recommends Final Dividend, for the Year Ended 31 March, 2024Balaji Amines Limited at the Board of Directors Meeting held on 8 May, 2024 recommended a final dividend of INR 11 per equity share 550% on face value of INR 2 per share, for the year ended 31 March, 2024 and the same will be payable after it is approved by the shareholders at the 36 Annual General Meeting of the Company.
공시 • May 03Balaji Amines Limited to Report Q4, 2024 Results on May 08, 2024Balaji Amines Limited announced that they will report Q4, 2024 results on May 08, 2024
분석 기사 • Apr 05There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
분석 기사 • Feb 15Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) ForecastsToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the covering analyst...
Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹15.24 (vs ₹19.31 in 3Q 2023)Third quarter 2024 results: EPS: ₹15.24 (down from ₹19.31 in 3Q 2023). Revenue: ₹3.92b (down 33% from 3Q 2023). Net income: ₹493.7m (down 21% from 3Q 2023). Profit margin: 13% (up from 11% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.
공시 • Jan 24Balaji Amines Limited to Report Q3, 2024 Results on Jan 31, 2024Balaji Amines Limited announced that they will report Q3, 2024 results on Jan 31, 2024
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,670, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,718 per share.
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,347, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 159% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,738 per share.
분석 기사 • Nov 24Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To BeToday is shaping up negative for Balaji Amines Limited ( NSE:BALAMINES ) shareholders, with the analysts delivering a...
Price Target Changed • Nov 22Price target decreased by 16% to ₹2,768Down from ₹3,278, the current price target is an average from 2 analysts. New target price is 36% above last closing price of ₹2,030. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹125 for next year compared to ₹100 last year.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹10.71 (vs ₹28.57 in 2Q 2023)Second quarter 2024 results: EPS: ₹10.71 (down from ₹28.57 in 2Q 2023). Revenue: ₹3.87b (down 39% from 2Q 2023). Net income: ₹347.1m (down 63% from 2Q 2023). Profit margin: 9.0% (down from 15% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Nov 03Balaji Amines Limited to Report Q2, 2024 Results on Nov 08, 2023Balaji Amines Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Reported Earnings • Sep 01First quarter 2024 earnings released: EPS: ₹16.28 (vs ₹37.95 in 1Q 2023)First quarter 2024 results: EPS: ₹16.28 (down from ₹37.95 in 1Q 2023). Revenue: ₹4.69b (down 31% from 1Q 2023). Net income: ₹527.3m (down 57% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Aug 22Balaji Amines Limited to Report Q1, 2024 Results on Aug 31, 2023Balaji Amines Limited announced that they will report Q1, 2024 results on Aug 31, 2023
분석 기사 • Jul 14Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?Key Insights Using the 2 Stage Free Cash Flow to Equity, Balaji Amines fair value estimate is ₹3,541 Current share...
공시 • Jul 13Balaji Amines Limited Approves Dividend for the Financial Year 2022-23Balaji Amines Limited at its AGM held on July 10, 2023, approved dividend of INR 10 per equity share for the financial Year 2022-23.
Upcoming Dividend • Jun 26Upcoming dividend of ₹10.00 per share at 0.4% yieldEligible shareholders must have bought the stock before 03 July 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).
Reported Earnings • Jun 24Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.6b (up 1.4% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Jun 22Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
공시 • Jun 17Balaji Amines Limited, Annual General Meeting, Jul 10, 2023Balaji Amines Limited, Annual General Meeting, Jul 10, 2023, at 16:00 Indian Standard Time.
분석 기사 • Jun 09Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last YearBalaji Amines Limited ( NSE:BALAMINES ) has announced that it will be increasing its dividend from last year's...
Reported Earnings • May 25Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: ₹100 (down from ₹114 in FY 2022). Revenue: ₹23.7b (up 2.0% from FY 2022). Net income: ₹3.26b (down 12% from FY 2022). Profit margin: 14% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 74% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 22+ 1 more updateBalaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial OfficerBalaji Amines Limited announced resignation of Hemanth Reddy Gaddam as Chief Financial Officer. The full-time director and CFO has resigned to focus on subsidiary company, Balaji Speciality Chemicals Ltd.
공시 • May 21+ 1 more updateBalaji Amines Limited Appoints Ande Srinivas Reddy as CFOBalaji Amines Limited at the SBM, the board approved appointment of Mr. Ande Srinivas Reddy (DIN: 03169721) as a Whole-time Director & CFO of the Company for remaining tenure of his appointment till 31st March, 2026.
공시 • May 14Balaji Amines Limited to Report Q4, 2023 Results on May 20, 2023Balaji Amines Limited announced that they will report Q4, 2023 results on May 20, 2023
Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,486, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 685% over the past three years.
Price Target Changed • Apr 05Price target decreased by 14% to ₹3,790Down from ₹4,428, the current price target is provided by 1 analyst. New target price is 78% above last closing price of ₹2,128. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹142 for next year compared to ₹114 last year.
분석 기사 • Apr 05Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?While Balaji Amines Limited ( NSE:BALAMINES ) might not be the most widely known stock at the moment, it saw...
Recent Insider Transactions • Mar 22MD & Whole Time Director recently bought ₹202k worth of stockOn the 16th of March, Dundurapu Reddy bought around 100 shares on-market at roughly ₹2,019 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. Dundurapu has been a buyer over the last 12 months, purchasing a net total of ₹419k worth in shares.
분석 기사 • Mar 15Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Recent Insider Transactions • Feb 22Joint MD & Whole-time Director recently bought ₹244k worth of stockOn the 16th of February, Nomula Reddy bought around 98.0 shares on-market at roughly ₹2,494 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.0m. This was Nomula's only on-market trade for the last 12 months.
분석 기사 • Feb 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under ThreatOne thing we could say about the analysts on Balaji Amines Limited ( NSE:BALAMINES ) - they aren't optimistic, having...
Recent Insider Transactions • Feb 14Executive Chairman recently bought ₹1.0m worth of stockOn the 10th of February, Ande Reddy bought around 480 shares on-market at roughly ₹2,166 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ande's only on-market trade for the last 12 months.
분석 기사 • Feb 08With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting CaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Feb 07Third quarter 2023 earnings released: EPS: ₹19.31 (vs ₹27.64 in 3Q 2022)Third quarter 2023 results: EPS: ₹19.31 (down from ₹27.64 in 3Q 2022). Revenue: ₹5.88b (up 4.2% from 3Q 2022). Net income: ₹625.7m (down 30% from 3Q 2022). Profit margin: 11% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has increased by 72% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jan 31Balaji Amines Limited to Report Q3, 2023 Results on Feb 06, 2023Balaji Amines Limited announced that they will report Q3, 2023 results on Feb 06, 2023
분석 기사 • Dec 25Balaji Amines (NSE:BALAMINES) Seems To Use Debt Quite SensiblyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
분석 기사 • Dec 02Why The 42% Return On Capital At Balaji Amines (NSE:BALAMINES) Should Have Your AttentionFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Price Target Changed • Nov 16Price target increased to ₹4,428Up from ₹4,115, the current price target is an average from 2 analysts. New target price is 50% above last closing price of ₹2,958. Stock is down 9.6% over the past year. The company is forecast to post earnings per share of ₹143 for next year compared to ₹114 last year.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 10 highly experienced directors. Independent Non-Executive Director Vimala Madon was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.